FI105917B - Menetelmä terapeuttisesti aktiivisen 5-kloori-2,3-dihydro-2,2-dimetyylibentsofuraani-7-karboksyylihappo-oktahydro-3-hydroksi-2,6-metano-2H-kinolitsin-8-yyliesterin valmistamiseksi - Google Patents

Menetelmä terapeuttisesti aktiivisen 5-kloori-2,3-dihydro-2,2-dimetyylibentsofuraani-7-karboksyylihappo-oktahydro-3-hydroksi-2,6-metano-2H-kinolitsin-8-yyliesterin valmistamiseksi Download PDF

Info

Publication number
FI105917B
FI105917B FI943872A FI943872A FI105917B FI 105917 B FI105917 B FI 105917B FI 943872 A FI943872 A FI 943872A FI 943872 A FI943872 A FI 943872A FI 105917 B FI105917 B FI 105917B
Authority
FI
Finland
Prior art keywords
ett
farm farm
methano
dihydro
chloro
Prior art date
Application number
FI943872A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI943872L (fi
FI943872A0 (fi
Inventor
Maurice Ward Gittos
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of FI943872L publication Critical patent/FI943872L/fi
Publication of FI943872A0 publication Critical patent/FI943872A0/fi
Application granted granted Critical
Publication of FI105917B publication Critical patent/FI105917B/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/18Bridged systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FI943872A 1992-02-24 1994-08-23 Menetelmä terapeuttisesti aktiivisen 5-kloori-2,3-dihydro-2,2-dimetyylibentsofuraani-7-karboksyylihappo-oktahydro-3-hydroksi-2,6-metano-2H-kinolitsin-8-yyliesterin valmistamiseksi FI105917B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP92400474 1992-02-24
EP92400474 1992-02-24
US9300880 1993-02-03
PCT/US1993/000880 WO1993017019A1 (en) 1992-02-24 1993-02-03 2,6-methano-2h-quinolizin derivative as 5-ht3-receptor antagonist

Publications (3)

Publication Number Publication Date
FI943872L FI943872L (fi) 1994-08-23
FI943872A0 FI943872A0 (fi) 1994-08-23
FI105917B true FI105917B (fi) 2000-10-31

Family

ID=8211614

Family Applications (1)

Application Number Title Priority Date Filing Date
FI943872A FI105917B (fi) 1992-02-24 1994-08-23 Menetelmä terapeuttisesti aktiivisen 5-kloori-2,3-dihydro-2,2-dimetyylibentsofuraani-7-karboksyylihappo-oktahydro-3-hydroksi-2,6-metano-2H-kinolitsin-8-yyliesterin valmistamiseksi

Country Status (14)

Country Link
EP (1) EP0628043A1 (enrdf_load_html_response)
JP (1) JPH07504192A (enrdf_load_html_response)
KR (1) KR100287933B1 (enrdf_load_html_response)
AU (1) AU675060B2 (enrdf_load_html_response)
CA (1) CA2130563C (enrdf_load_html_response)
FI (1) FI105917B (enrdf_load_html_response)
HU (1) HU216831B (enrdf_load_html_response)
IL (1) IL104821A (enrdf_load_html_response)
MX (1) MX9300948A (enrdf_load_html_response)
NO (1) NO943101L (enrdf_load_html_response)
NZ (1) NZ249346A (enrdf_load_html_response)
TW (1) TW226374B (enrdf_load_html_response)
WO (1) WO1993017019A1 (enrdf_load_html_response)
ZA (1) ZA931146B (enrdf_load_html_response)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2672500A (en) 1999-02-18 2000-09-04 Novartis Ag Systemic use of 5-ht3 receptor antagonists against rheumatic inflammatory processes
US8518962B2 (en) 2005-03-07 2013-08-27 The University Of Chicago Use of opioid antagonists
JP5241484B2 (ja) 2005-03-07 2013-07-17 ザ ユニヴァーシティー オヴ シカゴ 内皮細胞増殖及び内皮細胞遊走を減弱するためのオピオイドアンタゴニストの使用
US8524731B2 (en) 2005-03-07 2013-09-03 The University Of Chicago Use of opioid antagonists to attenuate endothelial cell proliferation and migration
US9662325B2 (en) 2005-03-07 2017-05-30 The University Of Chicago Use of opioid antagonists to attenuate endothelial cell proliferation and migration

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2080727T3 (es) * 1988-02-23 1996-02-16 Merrell Pharma Inc Uso de quinolizina y derivados de quinolizinona en la fabricacion de medicamentos.
EP0517984A1 (en) * 1991-06-11 1992-12-16 Merrell Dow Pharmaceuticals Inc. Derivatives of amide analogs of certain methano bridged quinolizines

Also Published As

Publication number Publication date
TW226374B (enrdf_load_html_response) 1994-07-11
NO943101D0 (no) 1994-08-23
KR950700297A (ko) 1995-01-16
MX9300948A (es) 1993-08-01
FI943872L (fi) 1994-08-23
ZA931146B (en) 1993-09-14
HUT68249A (en) 1995-06-28
CA2130563A1 (en) 1993-09-02
JPH07504192A (ja) 1995-05-11
EP0628043A1 (en) 1994-12-14
CA2130563C (en) 1997-11-11
AU3603493A (en) 1993-09-13
NO943101L (no) 1994-08-23
AU675060B2 (en) 1997-01-23
FI943872A0 (fi) 1994-08-23
NZ249346A (en) 1995-10-26
HU9402436D0 (en) 1994-10-28
IL104821A (en) 1997-01-10
IL104821A0 (en) 1993-06-10
HU216831B (hu) 1999-09-28
WO1993017019A1 (en) 1993-09-02
KR100287933B1 (ko) 2001-05-02

Similar Documents

Publication Publication Date Title
US5011846A (en) Medicament compositions derived from quinolizine and quinolizinone and methods of use thereof
NL8600555A (nl) Farmaceutische formuleringen en werkwijze voor de behandeling van geheugenstoornissen.
JP2657267B2 (ja) ヘキサヒドロ−8−ヒドロキシ−2,6−メタノ−2h−キノリジン−3(4h)−オンのエステル類及び関連化合物類
JP3462165B2 (ja) 神経筋遮断剤
EP0546181A1 (en) Indole derivatives and their use as serotonin antagonists
FI105917B (fi) Menetelmä terapeuttisesti aktiivisen 5-kloori-2,3-dihydro-2,2-dimetyylibentsofuraani-7-karboksyylihappo-oktahydro-3-hydroksi-2,6-metano-2H-kinolitsin-8-yyliesterin valmistamiseksi
JPH085787B2 (ja) 痴呆及び脳血管障害予防・治療剤並びに血小板凝集抑制剤
US5886011A (en) Piperidine derivatives as substance P antagonists
IE58883B1 (en) Nitrogen containing compounds
WO2010151258A1 (en) Methods of treating psychological conditions
CN1582282B (zh) 取代的四环系四氢呋喃衍生物的扁桃酸盐化合物
JPH0669951B2 (ja) 5ht▲下2▼受容体の選択的遮断剤
US5508287A (en) 2,6-methano-2H-quinolizin derivative as 5-HT3 -receptor antagonist
PT95526A (pt) Processo para a preparacao de derivados de 10,5-(iminometano)-5h-dibenzo{a,d}ciclo-hepteno uteis como agentes neuroprotectores
CA2090076A1 (en) Method for improving primary memory and/or learning
AU3241093A (en) Treatment of involuntary movements with 5HT-1A receptor agonists
DK175643B1 (da) Anvendelse af quinolizin- og quinolizinon-derivater ved fremstilling af lægemidler
US5910501A (en) Use of certain esters of hexahydro-8-hydroxy-2,6-methano-2H-quinolozin-3(4H)-one and related compounds for treating cognitive disorders
Shimizu-Sasamata et al. Cerebral activating properties of indeloxazine HCl and its optical isomers
NL8200491A (nl) 17, 18-dehydroapovincaminol-3'4',5'-trimethoxybenzoaat, de zuuradditiezouten ervan, tussenprodukten, alsmede werkwijzen ter bereiding van deze verbindingen.
JPH08503448A (ja) 5ht▲下1▼▲a▼受容体アゴニストによる不随意運動の処置
EP1163907A1 (en) Use of l-threo-methylphenidate for the treatment of depression
SK16052002A3 (sk) Enantioméry 2-aminotetralínových derivátov, spôsob ich prípravy, farmaceutické prostriedky s ich obsahom a ich použitie
FR2609715A1 (fr) Nouveaux diazepinoindoles, leur preparation et leur utilisation comme medicaments
JP2024519065A (ja) 向精神薬とその用途

Legal Events

Date Code Title Description
PC Transfer of assignment of patent

Owner name: AVENTIS INC.

Free format text: AVENTIS INC.

PC Transfer of assignment of patent

Owner name: AVENTISUB II INC.

Free format text: AVENTISUB II INC.

MA Patent expired